Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Cancer Immunotherapy-An Overview.
Current paradigm of EGFRins20 in non-small cell lung cancer: A long way forward.
Immunotherapy in Head and Neck Cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Current paradigm of EGFRins20 in non-small cell lung cancer: A long way forward.
Current paradigm of EGFRins20 in non-small cell lung cancer: A long way forward. Med. 2025 Sep 12; 6(9):100803.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
ErbB Receptors
Humans
Lung Neoplasms
Molecular Targeted Therapy
Mutation
Precision Medicine
Protein Kinase Inhibitors
authors with profiles
Ravi Salgia